We’ve long needed federal intervention to protect abortion rights, but it’s never been more urgent.
Creating a needle-free COVID-19 vaccine
Vaccines are mostly synonymous with needles, an efficient and effective way to provide immunity to myriad infections. As COVID-19 vaccination efforts roll out across the U.S. and the world, some experts believe that a vaccine administered through the nose could be just as effective and easier to administer. A cover story in Chemical & Engineering …
American Airlines CEO shows up at Southwest flight attendant’s wedding a year after their viral meeting
One year ago, Southwest Airlines flight attendant JacqueRae Sullivan was feeling overwhelmed by events in the United States following the death of George Floyd.
Newborns on ventilators can now be better protected from a common breathing tube incident
If a newborn is moved or becomes agitated while on a ventilator, the breathing tube also could move. Just a few seconds with the tube in the wrong position might lead to a critical lack of oxygen to the brain, possibly resulting in lifelong disability or brain damage or even ending the baby’s life.
The new AMD Radeon Pro GPUs look perfect for a powerful Mac Pro update
The new cards promise up to a 79% improvement over last-gen, which leaves the Mac Pro in a tough spot.
Understanding gut inflammation may hold clues to mitigating Parkinson’s onset
Chronic inflammation in the gut may propel processes in the body that give rise to Parkinson’s disease, according to a study by scientists at Van Andel Institute and Roche.
Hall of Fame Delays Jeter’s Induction, but Now Will Allow Fans
The ceremony for Derek Jeter, Larry Walker, Ted Simmons and Marvin Miller will now be an event requiring tickets in September.
Genshin Impact Klee guide: Best build, weapons, and artifacts
Klee is a powerhouse of a Pyro user in Genshin Impact, but she requires some older equipment. Here are the best build, weapons, and artifacts for Klee.
Disparities in treatment persist for people with headache
Disparities exist in the treatment of people with headache disorders because of race and ethnicity, socioeconomic status and geography, according to a review article published in the June 9, 2021, online issue of Neurology.
There’s a new Alzheimer’s drug, so what’s the problem? A doctor explains.
After years of disappointing studies of potential treatments for the more than 6 million people living with Alzheimer’s disease, the U.S. Food and Drug Administration recently approved a new drug called aducanumab that is sure to garner significant interest.